The effect of hydroxyethyl starch 200 kD on platelet function.

Area of Science:

• Hematology
• Pharmacology
• Biochemistry

Background:

• Hydroxyethyl starch (HES) is used as a plasma volume expander.
• The anticoagulant effects of HES require further mechanistic elucidation.
• Platelet function is crucial for hemostasis and thrombosis.

Purpose of the Study:

• To investigate the impact of HES 200 kD on platelet function.
• To identify the specific platelet surface glycoproteins affected by HES 200 kD.
• To understand the cellular mechanisms underlying HES 200 kD's anticoagulant properties.

Main Methods:

• Human subjects received intravenous infusions of saline or HES 200 kD.
• Flow cytometry assessed glycoprotein (GP) IIb-IIIa, GP Ib, and P-selectin expression on activated platelets.
• Thromboelastography (maximum amplitude) and platelet function analyzer-closure times evaluated overall platelet function.
• In vitro experiments confirmed concentration-dependent effects of HES 200 kD.

Main Results:

• HES 200 kD infusion significantly reduced GP IIb-IIIa expression on platelets.
• HES 200 kD decreased thromboelastographic maximum amplitude and prolonged closure times.
• No significant changes were observed in GP Ib or P-selectin expression.
• In vitro studies showed a concentration-dependent inhibition of GP IIb-IIIa expression by HES 200 kD.

Conclusions:

• Decreased availability of platelet GP IIb-IIIa is a key mechanism for the anticoagulant effects of HES 200 kD.
• HES 200 kD directly impacts platelet activation and function.
• These findings provide cellular insights into the hemostatic alterations associated with HES 200 kD administration.